$ARIA Recent News Ariad shares jump nearly 30% o
Post# of 72725
Posted On: 01/25/2014 9:52:01 AM
$ARIA Recent News
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Analyst Reason No. 345 to Upgrade Biotech Stocks: Takeover Rumors in the Foreign Press! 3:40 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Shares Continue to Surge Amidst Buyout Rumors 3:06 p.m. Jan. 24, 2014 - benzinga.com
Ariad Pharnaceuticals Continues To Rally 2:32 p.m. Jan. 24, 2014 - benzinga.com
Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft Provides on of the Few Havens of Strength 2:32 p.m. Jan. 24, 2014 - benzinga.com
Why Ariad Pharmaceuticals (ARIA) Hit a Three-Month High Today 1:58 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Surges: Stock Moves 12.1% Higher - Tale of the Tape 9:18 a.m. Jan. 24, 2014 - Zacks.com
Top Trending Tickers On StockTwits For January 23 10:15 a.m. Jan. 23, 2014 - benzinga.com
Why Ariad Pharmaceuticals (ARIA) Is Up Today 10:13 a.m. Jan. 23, 2014 - TheStreet.com
Ariad Joins Rumor Mill: Hope May Trump Reality 9:54 a.m. Jan. 23, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Gainers 7:09 a.m. Jan. 23, 2014 - benzinga.com
ARIA Stock – Ariad Shares Pop on Potential Buyout Rumors 3:34 a.m. Jan. 23, 2014 - InvestorPlace.com
Benzinga's M&A Chatter for Wednesday January 22, 2014 5:31 p.m. Jan. 22, 2014 - benzinga.com
Ariad +4.3% AH, Daily Mail reports that pharmas are circling 5:19 p.m. Jan. 22, 2014 - Seeking Alpha
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Why Actavis (ACT) Has A Bright Short-Term Future? - Tale of the Tape 8:42 a.m. Jan. 22, 2014 - Zacks.com
ARIAD's Iclusig Returns to U.S. - Analyst Blog 6:10 p.m. Jan. 21, 2014 - Zacks.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Jan. 21, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Is Today's Pre-Market Mover With Heavy Volume Stock 8:57 a.m. Jan. 17, 2014 - TheStreet.com
Ariad +9%, reports commercial availability of Iclusig for adult CML patients 8:25 a.m. Jan. 17, 2014 - Seeking Alpha
ARIAD Announces Commercial Availability of Iclusig for Patients with Refractory Philadelphia-Positive Leukemias in US 6:36 a.m. Jan. 17, 2014 - benzinga.com
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Analyst Reason No. 345 to Upgrade Biotech Stocks: Takeover Rumors in the Foreign Press! 3:40 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Shares Continue to Surge Amidst Buyout Rumors 3:06 p.m. Jan. 24, 2014 - benzinga.com
Ariad Pharnaceuticals Continues To Rally 2:32 p.m. Jan. 24, 2014 - benzinga.com
Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft Provides on of the Few Havens of Strength 2:32 p.m. Jan. 24, 2014 - benzinga.com
Why Ariad Pharmaceuticals (ARIA) Hit a Three-Month High Today 1:58 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Surges: Stock Moves 12.1% Higher - Tale of the Tape 9:18 a.m. Jan. 24, 2014 - Zacks.com
Top Trending Tickers On StockTwits For January 23 10:15 a.m. Jan. 23, 2014 - benzinga.com
Why Ariad Pharmaceuticals (ARIA) Is Up Today 10:13 a.m. Jan. 23, 2014 - TheStreet.com
Ariad Joins Rumor Mill: Hope May Trump Reality 9:54 a.m. Jan. 23, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Gainers 7:09 a.m. Jan. 23, 2014 - benzinga.com
ARIA Stock – Ariad Shares Pop on Potential Buyout Rumors 3:34 a.m. Jan. 23, 2014 - InvestorPlace.com
Benzinga's M&A Chatter for Wednesday January 22, 2014 5:31 p.m. Jan. 22, 2014 - benzinga.com
Ariad +4.3% AH, Daily Mail reports that pharmas are circling 5:19 p.m. Jan. 22, 2014 - Seeking Alpha
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Why Actavis (ACT) Has A Bright Short-Term Future? - Tale of the Tape 8:42 a.m. Jan. 22, 2014 - Zacks.com
ARIAD's Iclusig Returns to U.S. - Analyst Blog 6:10 p.m. Jan. 21, 2014 - Zacks.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Jan. 21, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Is Today's Pre-Market Mover With Heavy Volume Stock 8:57 a.m. Jan. 17, 2014 - TheStreet.com
Ariad +9%, reports commercial availability of Iclusig for adult CML patients 8:25 a.m. Jan. 17, 2014 - Seeking Alpha
ARIAD Announces Commercial Availability of Iclusig for Patients with Refractory Philadelphia-Positive Leukemias in US 6:36 a.m. Jan. 17, 2014 - benzinga.com
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼